martes, 30 de septiembre de 2014

National Guideline Clearinghouse | Recommendations for drug therapies for relapsing-remitting multiple sclerosis.

full-text ►

National Guideline Clearinghouse | Recommendations for drug therapies for relapsing-remitting multiple sclerosis.





Canadian Agency for Drugs and Technologies in Health

National Guideline Clearinghouse (NGC)

Guideline Title
Recommendations for drug therapies for relapsing-remitting multiple sclerosis.
Bibliographic Source(s)
Canadian Agency for Drugs and Technologies in Health (CADTH). Recommendations for drug therapies for relapsing-remitting multiple sclerosis. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (CADTH); 2013 Oct. 19 p. [44 references]
Guideline Status
This is the current release of the guideline.
This guideline meets NGC's 2013 (revised) inclusion criteria.

No hay comentarios:

Publicar un comentario